FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2774713064> ?p ?o ?g. }

• W2774713064 endingPage "196" @default.
• W2774713064 startingPage "191" @default.
• W2774713064 abstract "Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD.This randomized, double-blind, placebo-controlled trial was conducted and involved 60 diabetic patients with CHD. Subjects were randomly allocated into two groups to receive either 10 mg melatonin (2 melatonin capsules, 5 mg each) (n = 30) or placebo (n = 30) once a day for 12 weeks.Compared with the placebo, melatonin supplementation resulted in significant increases in plasma glutathione (GSH) (+64.7 ± 105.7 vs. -11.1 ± 137.6 μmol/L, P = 0.02) and nitric oxide (NO) (+0.9 ± 4.7 vs. -3.3 ± 9.6 μmol/L, P = 0.03), and significant decreases in malondialdehyde (MDA) (-0.2 ± 0.3 vs. +0.1 ± 0.5 μmol/L, P = 0.007), protein carbonyl (PCO) (-0.12 ± 0.08 vs. +0.03 ± 0.07 mmol/mg protein, P < 0.001) and serum high sensitivity C-reactive protein (hs-CRP) levels (-1463.3 ± 2153.8 vs. +122.9 ± 1230.4 ng/mL, P = 0.001). In addition, taking melatonin, compared with the placebo, significantly reduced fasting plasma glucose (-29.4 ± 49.0 vs. -5.5 ± 32.4 mg/dL, P = 0.03), serum insulin concentrations (-2.2 ± 4.1 vs. +0.7 ± 4.2 μIU/mL, P = 0.008), homeostasis model of assessment-estimated insulin resistance (-1.0 ± 2.2 vs. +0.01 ± 1.6, P = 0.04), total-/HDL-cholesterol ratio (-0.18 ± 0.38 vs. +0.03 ± 0.35, P = 0.02) and systolic (-4.3 ± 9.6 vs. +1.0 ± 7.5 mmHg, P = 0.01) and diastolic blood pressure (-2.8 ± 7.3 vs. +0.1 ± 3.6 mmHg, P = 0.04). Melatonin treatment also significantly increased quantitative insulin sensitivity check index (+0.006 ± 0.01 vs. -0.004 ± 0.01, P = 0.01) and serum HDL-cholesterol (+2.6 ± 5.5 vs. -0.01 ± 4.4 mg/dL, P = 0.04). Supplementation with melatonin had no significant effect on other metabolic parameters.Overall, melatonin intake for 12 weeks to diabetic patients with CHD had beneficial effects on plasma GSH, NO, MDA, PCO, serum hs-CRP levels, glycemic control, HDL-cholesterol, total-/HDL-cholesterol ratio, blood pressures and parameters of mental health. Registered under ClinicalTrials.gov Identifier no. http://www.irct.ir: IRCT2017051333941N1." @default.
• W2774713064 created "2017-12-22" @default.
• W2774713064 creator A5063159500 @default.
• W2774713064 creator A5065652905 @default.
• W2774713064 creator A5071546635 @default.
• W2774713064 creator A5079861489 @default.
• W2774713064 creator A5082100318 @default.
• W2774713064 date "2019-02-01" @default.
• W2774713064 modified "2023-10-18" @default.
• W2774713064 title "Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial" @default.
• W2774713064 cites W1505050831 @default.
• W2774713064 cites W1567614586 @default.
• W2774713064 cites W1982974848 @default.
• W2774713064 cites W2005709289 @default.
• W2774713064 cites W2006761570 @default.
• W2774713064 cites W2025517512 @default.
• W2774713064 cites W2040483081 @default.
• W2774713064 cites W2046005854 @default.
• W2774713064 cites W2048118960 @default.
• W2774713064 cites W2066375555 @default.
• W2774713064 cites W2067495470 @default.
• W2774713064 cites W2100741632 @default.
• W2774713064 cites W2121214240 @default.
• W2774713064 cites W2123350325 @default.
• W2774713064 cites W2142433177 @default.
• W2774713064 cites W2150473784 @default.
• W2774713064 cites W2158106881 @default.
• W2774713064 cites W2160689800 @default.
• W2774713064 cites W2165292984 @default.
• W2774713064 cites W2166057024 @default.
• W2774713064 cites W2168893898 @default.
• W2774713064 cites W2332559724 @default.
• W2774713064 cites W2479394673 @default.
• W2774713064 cites W2586347576 @default.
• W2774713064 cites W2617865356 @default.
• W2774713064 cites W2620800810 @default.
• W2774713064 cites W4238079920 @default.
• W2774713064 doi "https://doi.org/10.1016/j.clnu.2017.12.004" @default.
• W2774713064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29275919" @default.
• W2774713064 hasPublicationYear "2019" @default.
• W2774713064 type Work @default.
• W2774713064 sameAs 2774713064 @default.
• W2774713064 citedByCount "85" @default.
• W2774713064 countsByYear W27747130642018 @default.
• W2774713064 countsByYear W27747130642019 @default.
• W2774713064 countsByYear W27747130642020 @default.
• W2774713064 countsByYear W27747130642021 @default.
• W2774713064 countsByYear W27747130642022 @default.
• W2774713064 countsByYear W27747130642023 @default.
• W2774713064 crossrefType "journal-article" @default.
• W2774713064 hasAuthorship W2774713064A5063159500 @default.
• W2774713064 hasAuthorship W2774713064A5065652905 @default.
• W2774713064 hasAuthorship W2774713064A5071546635 @default.
• W2774713064 hasAuthorship W2774713064A5079861489 @default.
• W2774713064 hasAuthorship W2774713064A5082100318 @default.
• W2774713064 hasConcept C126322002 @default.
• W2774713064 hasConcept C134018914 @default.
• W2774713064 hasConcept C142724271 @default.
• W2774713064 hasConcept C204787440 @default.
• W2774713064 hasConcept C27081682 @default.
• W2774713064 hasConcept C2776151105 @default.
• W2774713064 hasConcept C2777391703 @default.
• W2774713064 hasConcept C2778182776 @default.
• W2774713064 hasConcept C2778401633 @default.
• W2774713064 hasConcept C2778535154 @default.
• W2774713064 hasConcept C2778901321 @default.
• W2774713064 hasConcept C2779306644 @default.
• W2774713064 hasConcept C3017594256 @default.
• W2774713064 hasConcept C555293320 @default.
• W2774713064 hasConcept C71924100 @default.
• W2774713064 hasConceptScore W2774713064C126322002 @default.
• W2774713064 hasConceptScore W2774713064C134018914 @default.
• W2774713064 hasConceptScore W2774713064C142724271 @default.
• W2774713064 hasConceptScore W2774713064C204787440 @default.
• W2774713064 hasConceptScore W2774713064C27081682 @default.
• W2774713064 hasConceptScore W2774713064C2776151105 @default.
• W2774713064 hasConceptScore W2774713064C2777391703 @default.
• W2774713064 hasConceptScore W2774713064C2778182776 @default.
• W2774713064 hasConceptScore W2774713064C2778401633 @default.
• W2774713064 hasConceptScore W2774713064C2778535154 @default.
• W2774713064 hasConceptScore W2774713064C2778901321 @default.
• W2774713064 hasConceptScore W2774713064C2779306644 @default.
• W2774713064 hasConceptScore W2774713064C3017594256 @default.
• W2774713064 hasConceptScore W2774713064C555293320 @default.
• W2774713064 hasConceptScore W2774713064C71924100 @default.
• W2774713064 hasIssue "1" @default.
• W2774713064 hasLocation W27747130641 @default.
• W2774713064 hasLocation W27747130642 @default.
• W2774713064 hasOpenAccess W2774713064 @default.
• W2774713064 hasPrimaryLocation W27747130641 @default.
• W2774713064 hasRelatedWork W138803513 @default.
• W2774713064 hasRelatedWork W1986132654 @default.
• W2774713064 hasRelatedWork W2010140898 @default.
• W2774713064 hasRelatedWork W2010484394 @default.
• W2774713064 hasRelatedWork W2032225465 @default.
• W2774713064 hasRelatedWork W2056849036 @default.
• W2774713064 hasRelatedWork W2068756512 @default.
• W2774713064 hasRelatedWork W2082140668 @default.

• next